HemaSphere

Up a level
Export as [feed] RSS
Group by: Date | Full Text Status
Jump to: Public
Number of items: 13.

Public

Shumilov, Evgenyi; Novak, Urban; Jeker, Barbara; Mansouri Taleghani, Behrouz; Bacher, Ulrike; Pabst, Thomas (2019). Hematopoietic Stem Cell Mobilization With Plerixafor Is Safe and Effective in Poorly Mobilizing Acute Myeloid Leukemia Patients. HemaSphere, 3(2), e176. Wolters Kluwer Health 10.1097/HS9.0000000000000176

Schnell, Bianca R.; Seipel, Katja; Bacher, Ulrike; Jeker, Barbara; Mueller, Beatrice U.; Banz, Yara; Novak, Urban; Pabst, Thomas (2019). Rebound Thrombocytosis after Induction Chemotherapy is a Strong Biomarker for Favorable Outcome in AML Patients. HemaSphere, 3(2), e180. Wolters Kluwer Health 10.1097/HS9.0000000000000180

Balduini, Carlo; Freson, Kathleen; Greinacher, Andreas; Gresele, Paolo; Kühne, Thomas; Scully, Marie; Bakchoul, Tamam; Coppo, Paul; Dovc Drnovsek, Tadeja; Godeau, Bertrand; Gruel, Yves; Rao, A Koneti; Kremer Hovinga, Johanna A.; Makris, Michael; Matzdorff, Axel; Mumford, Andrew; Pecci, Alessandro; Raslova, Hana; Rivera, José; Roberts, Irene; ... (2021). The EHA Research Roadmap: Platelet Disorders. HemaSphere, 5(7), e601. Wolters Kluwer Health 10.1097/HS9.0000000000000601

Müller, Jan; Porret, Naomi; Rüfer, Axel (2021). Identification of a JAK2 FERM Domain Variant Associated With Hereditary Thrombocytosis. HemaSphere, 5(8), e626. Wolters Kluwer Health 10.1097/HS9.0000000000000626

Rössler, Jochen Karl; Baumgartner, Iris; Kremer Hovinga, Johanna A. (2021). EHA Endorsement of the Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia. HemaSphere, 5(11), e647. Wolters Kluwer Health 10.1097/HS9.0000000000000647

Rüfer, Axel; Angermann, Hubert; Benz, Rudolf; Bonadies, Nicolas; Calderoni, Antonello; Cantoni, Nathan; Efthymiou, Anna; Escher, Robert; Favre, Geneviève; Friess, Dorothea; Gschwend, Andreas; Himmelmann, Andreas; Holbro, Andreas; Keller, Peter; Kouroupi, Eirini; Lehmann, Thomas; Pedarnig, Nikolaus; Rigamonti, Véronique; Samii, Kaveh; Schmidt, Adrian; ... (2022). Real-world Data From the Swiss Lenalidomide in MDS del(5q) (SLIM)-Registry Identify New Chances and Challenges in Lenalidomide Treatment of Patients With MDS del(5q). HemaSphere, 6(7), e741. Wolters Kluwer Health 10.1097/HS9.0000000000000741

Stanworth, Simon J; Brand, Anneke; Kaveri, Srini V; Vrielink, Hans; Greinacher, Andreas; Domanović, Dragoslav; von Lindern, Marieke; Allard, Shubha; Bayry, Jagadeesh; Bohonek, Milos; Buser, Andreas; Claas, Frans H J; Knutson, Folke; Lozano, Miguel; Olsson, Martin L; Pirenne, France; Rebulla, Paolo; So-Osman, Cynthia; Tissot, Jean-Daniel; Toye, Ashley M; ... (2022). The EHA Research Roadmap: Transfusion Medicine. HemaSphere, 6(2), e670. Wolters Kluwer Health 10.1097/HS9.0000000000000670

Wondergem, Marielle J; Almeida, Antonio; Brolin, Janaki; Fernandez de Larrea, Carlos; van Havre, Nathalie; Hemker, Bas T; Hollegien, Wietske; Navarro, José-Tomás; Prahladan, Mahesh; Rovó, Alicia; Birgegård, Gunnar (2022). The Progress Test of the European Hematology Association: A New Tool for Continuous Learning. HemaSphere, 6(12), e815. Wolters Kluwer Health 10.1097/HS9.0000000000000815

Tettero, Jesse M; Buisman, Yara; Ngai, Lok Lam; Bachas, Costa; Gjertsen, Bjorn T; Kelder, Angèle; van de Loosdrecht, Arjan A; Manz, Markus G; Pabst, Thomas; Scholten, Willemijn; Ossenkoppele, Gert J; Cloos, Jacqueline; de Leeuw, David C (2023). Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML. HemaSphere, 7(12), e981. Wolters Kluwer Health 10.1097/HS9.0000000000000981

Shumilov, Evgenii; Boyadzhiev, Hristo; Mazzeo, Paolo; Akhoundova, Dilara; Daskalakis, Michael; Novak, Urban; Lenz, Georg; Bacher, Ulrike; Pabst, Thomas (2023). CAR-T Cell Therapy Shows Similar Efficacy and Toxicity in Patients With DLBCL Regardless of CNS Involvement. HemaSphere, 7(12), e984. Wolters Kluwer Health 10.1097/HS9.0000000000000984

Brkic, Sime; Meyer, Sara C. (2021). Challenges and Perspectives for Therapeutic Targeting of Myeloproliferative Neoplasms. HemaSphere, 5(1), e516. Wolters Kluwer Health 10.1097/HS9.0000000000000516

Berning, Philipp; Shumilov, Evgenii; Maulhardt, Markus; Boyadzhiev, Hristo; Kerkhoff, Andrea; Call, Simon; Reicherts, Christian; Saidy, Anna O.; Aydilek, Enver; Hoffmann, Michèle; Novak, Urban; Daskalakis, Michael; Schmitz, Norbert; Stelljes, Matthias; Wulf, Gerald; Bacher, Ulrike; Lenz, Georg; Pabst, Thomas Niklaus (2024). Chimeric antigen receptor-T cell therapy shows similar efficacy and toxicity in patients with diffuse large B-cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort study. HemaSphere, 8(3), pp. 1-12. Wiley 10.1002/hem3.54

Ferreri, Andreas J M; Illerhaus, Gerald; Doorduijn, Jeanette K; Auer, Dorothee P; Bromberg, Jacoline E C; Calimeri, Teresa; Cwynarski, Kate; Fox, Christopher P; Hoang-Xuan, Khê; Malaise, Denis; Ponzoni, Maurilio; Schorb, Elisabeth; Soussain, Carole; Specht, Lena; Zucca, Emanuele; Buske, Christian; Jerkeman, Mats; Dreyling, Martin (2024). Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. HemaSphere, 8(6) Wolters Kluwer Health 10.1002/hem3.89

This list was generated on Wed Sep 18 14:58:52 2024 CEST.
Provide Feedback